LEWIS JOSEPH
Insider CIK 1015747 · INSG Director, 10% owner · ESPR 10% owner · EBIO 10% owner · SPHS 10% owner · MRTX 10% owner · PMVP · ODT 10% owner · RAIN 10% owner · PAND 10% owner · ITOS 10% owner · TNGX Director, 10% owner · TYRA 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INSG INSEEGO CORP. | A Award | 2026-09-11 | 2026-09-15 | 19,654 | — | $0 | 72,425 | SEC↗ |
| INSG INSEEGO CORP. | A Award | 2026-09-11 | 2026-09-15 | 19,654 | — | $0 | 72,425 | SEC↗ |
| INSG INSEEGO CORP. | A Award | 2025-09-12 | 2025-09-15 | 9,427 | — | $0 | 52,771 | SEC↗ |
| INSG INSEEGO CORP. | J Other deriv | 2024-11-06 | 2024-11-12 | 453,528 | — | $0 | 453,528 | SEC↗ |
| INSG INSEEGO CORP. | J Other | 2024-11-06 | 2024-11-12 | 697,736 | — | $0 | 1,756,842 | SEC↗ |
| INSG INSEEGO CORP. | A Award | 2024-09-30 | 2024-10-02 | 7,655 | — | $0 | 43,344 | SEC↗ |
| INSG INSEEGO CORP. | A Award deriv | 2024-06-28 | 2024-07-02 | 465,385 | — | $0 | 465,385 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | A Award | 2024-05-10 | 2024-05-14 | 1,142,857 | $17.50 | $20.00M | 2,946,915 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award deriv | 2024-02-06 | 2024-02-08 | 705,280 | $13.01 | $9.18M | 705,280 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | A Award | 2024-02-06 | 2024-02-08 | 63,412 | $13.01 | $825.0K | 85,939 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-25 | 1,413,475 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-25 | 3,578,036 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer deriv | 2024-01-23 | 2024-01-25 | 332,809 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-25 | 287,866 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-25 | 30,518 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-25 | 3,201,440 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-25 | 203,754 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | D To issuer | 2024-01-23 | 2024-01-25 | 3,135,966 | — | $0 | 0 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2023-10-16 | 2023-10-17 | 500,000 | $6.84 | $3.42M | 8,198,642 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2023-10-16 | 2023-10-17 | 500,000 | $6.84 | $3.42M | 8,198,642 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2023-10-13 | 2023-10-17 | 750,000 | $7.07 | $5.30M | 7,698,642 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2023-10-13 | 2023-10-17 | 750,000 | $7.07 | $5.30M | 7,698,642 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2023-10-09 | 2023-10-11 | 175,000 | $9.97 | $1.74M | 6,948,642 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | S Sale | 2023-10-09 | 2023-10-11 | 50,000 | $9.91 | $495.5K | 693,524 | SEC↗ |
| INSG INSEEGO CORP. | A Award | 2023-09-29 | 2023-10-03 | 215,517 | — | $0 | 356,903 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2023-08-23 | 2023-08-25 | 219,638 | $16.87 | $3.71M | 1,804,058 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2023-08-23 | 2023-08-25 | 95,516 | $15.63 | $1.49M | 2,023,696 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2023-08-23 | 2023-08-25 | 34,846 | $14.19 | $494.5K | 2,119,212 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award deriv | 2023-08-11 | 2023-10-11 | 2,340,579 | $5.15 | $12.05M | 2,340,579 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | A Award | 2023-08-11 | 2023-10-11 | 475,000 | $5.15 | $2.45M | 743,542 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy deriv | 2023-08-11 | 2023-08-15 | 2,340,579 | $5.15 | $12.05M | 2,340,597 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2023-08-11 | 2023-08-15 | 475,000 | $5.15 | $2.45M | 743,542 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2023-08-11 | 2023-08-15 | 57,533 | $27.80 | $1.60M | 287,866 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2023-08-11 | 2023-08-15 | 1,201,440 | $27.80 | $33.40M | 3,201,440 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2023-08-11 | 2023-08-15 | 1,201,440 | $27.80 | $33.40M | 3,201,440 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2023-08-11 | 2023-08-15 | 57,533 | $27.80 | $1.60M | 287,866 | SEC↗ |
| RAIN Rain Oncology Inc. | S Sale | 2023-05-22 | 2023-05-24 | 995,000 | $1.25 | $1.24M | 1,152,212 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2022-10-13 | 2022-10-13 | 70,000 | $4.65 | $325.5K | 7,123,642 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2022-10-12 | 2022-10-13 | 50,000 | $4.43 | $221.5K | 268,524 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2022-10-11 | 2022-10-13 | 117,000 | $4.25 | $497.3K | 218,524 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2022-10-06 | 2022-10-06 | 70,394 | $4.06 | $285.8K | 7,053,642 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2022-10-05 | 2022-10-06 | 45,500 | $3.93 | $178.8K | 6,942,748 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2022-10-05 | 2022-10-06 | 40,500 | $3.84 | $155.5K | 6,983,248 | SEC↗ |
| TNGX Tango Therapeutics, Inc. | P Buy | 2022-10-04 | 2022-10-06 | 25,606 | $3.67 | $94.0K | 6,897,248 | SEC↗ |
| INSG INSEEGO CORP. | A Award | 2022-08-03 | 2022-08-05 | 49,801 | — | $0 | 141,386 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-03-17 | 2022-03-18 | 575,201 | $35.25 | $20.28M | 3,142,058 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 88,054 | $41.84 | $3.68M | 3,767,405 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 11,199 | $44.44 | $497.7K | 2,517 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 3,138 | $43.36 | $136.1K | 13,716 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 29,623 | $41.84 | $1.24M | 16,854 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 7,483 | $45.48 | $340.3K | 3,717,259 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 33,297 | $44.44 | $1.48M | 3,724,742 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 9,366 | $43.36 | $406.1K | 3,758,039 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-05 | 2,517 | $45.48 | $114.5K | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-03 | 2022-01-05 | 731 | $50.63 | $37.0K | 46,477 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-03 | 2022-01-05 | 1,682 | $49.37 | $83.0K | 47,208 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-03 | 2022-01-05 | 23,353 | $47.63 | $1.11M | 48,890 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-03 | 2022-01-05 | 17,173 | $50.63 | $869.5K | 3,855,459 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-03 | 2022-01-05 | 39,481 | $49.37 | $1.95M | 3,872,632 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-03 | 2022-01-05 | 432,903 | $47.65 | $20.63M | 3,912,113 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | P Buy | 2021-12-17 | 2021-12-21 | 125,000 | $13.12 | $1.64M | 6,448,359 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | S Sale | 2021-11-24 | 2021-11-24 | 200,000 | $1.57 | $314.0K | 4,207,086 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | S Sale | 2021-11-22 | 2021-11-24 | 200,000 | $1.55 | $310.0K | 4,407,086 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | S Sale | 2021-11-19 | 2021-11-19 | 150,000 | $1.84 | $276.0K | 4,607,086 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | S Sale | 2021-11-18 | 2021-11-19 | 250,000 | $1.95 | $487.5K | 4,757,086 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | S Sale | 2021-11-17 | 2021-11-19 | 600,000 | $2.17 | $1.30M | 5,007,086 | SEC↗ |
| INSG INSEEGO CORP. | D To issuer | 2021-09-22 | 2021-09-24 | 7,000 | — | $0 | 0 | SEC↗ |
| INSG INSEEGO CORP. | A Award | 2021-09-22 | 2021-09-24 | 1,067,645 | — | $0 | 14,908,149 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-17 | 1,480,242 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-17 | 15,401 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-17 | 713,629 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion deriv | 2021-09-17 | 2021-09-17 | 95,516 | — | $0 | 0 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion | 2021-09-17 | 2021-09-17 | 288,095 | — | $0 | 288,095 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | P Buy | 2021-09-17 | 2021-09-17 | 625,000 | $16.00 | $10.00M | 6,323,359 | SEC↗ |
| TYRA Tyra Biosciences, Inc. | C Conversion | 2021-09-17 | 2021-09-17 | 5,698,359 | — | $0 | 5,698,359 | SEC↗ |
| INSG INSEEGO CORP. | A Award | 2021-07-28 | 2021-07-30 | 14,221 | — | $0 | 91,585 | SEC↗ |
| INSG INSEEGO CORP. | A Award | 2021-05-04 | 2021-05-11 | 6,242 | — | $0 | 77,364 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion deriv | 2021-04-27 | 2021-04-27 | 3,263,986 | — | $0 | 3,022,489 | SEC↗ |
| RAIN Rain Therapeutics Inc. | C Conversion deriv | 2021-04-27 | 2021-04-27 | 3,022,489 | — | $0 | 79,726 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2021-04-27 | 2021-04-27 | 1,025,000 | $17.00 | $17.43M | 1,175,000 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2021-04-23 | 2021-04-27 | 125,000 | $16.27 | $2.03M | 150,000 | SEC↗ |
| RAIN Rain Therapeutics Inc. | P Buy | 2021-04-23 | 2021-04-27 | 25,000 | $15.58 | $389.5K | 25,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-10 | 2021-03-10 | 189 | $195.52 | $37.0K | 3,135,777 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-10 | 2021-03-10 | 1 | $195.90 | $196 | 3,135,966 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2021-03-10 | 2021-03-10 | 410 | — | $0 | 3,135,967 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-10 | 2021-03-10 | 200 | $198.00 | $39.6K | 3,135,557 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-10 | 2021-03-10 | 20 | $196.12 | $3.9K | 3,135,757 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-09 | 2021-03-10 | 1,107 | $195.82 | $216.8K | 3,134,859 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-09 | 2021-03-10 | 4,633 | $197.30 | $914.1K | 3,130,226 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-09 | 2021-03-10 | 1 | $191.00 | $191 | 3,135,966 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2021-03-09 | 2021-03-10 | 11,971 | — | $0 | 3,135,967 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-09 | 2021-03-10 | 2,237 | $199.08 | $445.3K | 3,123,996 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-09 | 2021-03-10 | 3,993 | $197.81 | $789.9K | 3,126,233 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2021-03-05 | 2021-03-09 | 468,639 | $13.00 | $6.09M | 332,809 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2021-03-05 | 2021-03-09 | 128,805 | $5.60 | $721.3K | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2021-03-05 | 2021-03-09 | 13,996 | $5.60 | $78.4K | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-05 | 2021-03-09 | 4 | $181.00 | $724 | 2,363,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2021-03-05 | 2021-03-09 | 13,996 | — | $0 | 267,334 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-05 | 2021-03-09 | 363,000 | $181.15 | $65.76M | 2,000,000 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-05 | 2021-03-09 | 1 | $181.00 | $181 | 267,333 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2021-03-05 | 2021-03-09 | 597,444 | — | $0 | 2,363,004 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2021-03-05 | 2021-03-09 | 37,000 | $181.15 | $6.70M | 230,333 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2020-12-30 | 2020-12-30 | 100,000 | $17.46 | $1.75M | 5,607,086 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2020-12-28 | 2020-12-30 | 75,000 | $16.90 | $1.27M | 5,282,086 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2020-12-28 | 2020-12-30 | 225,000 | $17.11 | $3.85M | 5,507,086 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-10-30 | 2020-10-30 | 37,051 | $5.60 | $207.5K | 13,996 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-10-30 | 2020-10-30 | 362,952 | $5.60 | $2.03M | 128,805 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-30 | 2020-10-30 | 37,050 | $202.00 | $7.48M | 216,288 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | F Tax w/h | 2020-10-30 | 2020-10-30 | 2 | $219.97 | $440 | 1,765,560 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-10-30 | 2020-10-30 | 362,952 | — | $0 | 1,765,562 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-30 | 2020-10-30 | 362,950 | $202.00 | $73.32M | 1,404,610 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | F Tax w/h | 2020-10-30 | 2020-10-30 | 1 | $219.97 | $220 | 253,338 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-10-30 | 2020-10-30 | 37,051 | — | $0 | 253,339 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-10-29 | 2020-10-30 | 104,565 | $5.60 | $585.6K | 3,590,421 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 11,656 | $216.06 | $2.52M | 3,045,570 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 27,992 | $215.08 | $6.02M | 3,057,226 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 2,344 | $214.31 | $502.3K | 3,085,218 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 3,108 | $212.66 | $660.9K | 3,087,562 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 14,408 | $211.50 | $3.05M | 3,090,670 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 10,599 | $210.58 | $2.23M | 3,105,078 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 15,091 | $209.66 | $3.16M | 3,115,677 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 1,674 | $208.78 | $349.5K | 3,130,768 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 1,086 | $207.96 | $225.8K | 3,132,442 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 1,088 | $206.50 | $224.7K | 3,133,528 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 800 | $205.64 | $164.5K | 3,134,616 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 550 | $203.32 | $111.8K | 3,135,416 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 6,775 | $217.14 | $1.47M | 3,038,795 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 5,912 | $218.04 | $1.29M | 3,032,883 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 663 | $218.85 | $145.1K | 3,032,220 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-29 | 2020-10-30 | 818 | $220.02 | $180.0K | 3,031,402 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-10-29 | 2020-10-30 | 104,565 | — | $0 | 3,135,967 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | F Tax w/h | 2020-10-29 | 2020-10-30 | 1 | $202.25 | $202 | 3,135,966 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-10-28 | 2020-10-30 | 295,438 | $5.60 | $1.65M | 3,694,986 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-28 | 2020-10-30 | 38,543 | $204.57 | $7.88M | 3,052,464 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-28 | 2020-10-30 | 45,896 | $205.49 | $9.43M | 3,006,568 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-28 | 2020-10-30 | 41,266 | $206.50 | $8.52M | 2,965,302 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-28 | 2020-10-30 | 38,525 | $207.35 | $7.99M | 2,926,777 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-28 | 2020-10-30 | 25,036 | $208.40 | $5.22M | 2,901,741 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-28 | 2020-10-30 | 37,428 | $209.47 | $7.84M | 2,864,313 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-28 | 2020-10-30 | 23,283 | $210.31 | $4.90M | 2,841,030 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-28 | 2020-10-30 | 500 | $211.06 | $105.5K | 2,840,530 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise | 2020-10-28 | 2020-10-30 | 295,438 | — | $0 | 3,135,968 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | F Tax w/h | 2020-10-28 | 2020-10-30 | 2 | $209.16 | $418 | 3,135,966 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale | 2020-10-28 | 2020-10-30 | 44,959 | $203.35 | $9.14M | 3,091,007 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 32,708 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 586,099 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 732,137 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 28,129 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion | 2020-09-29 | 2020-09-29 | 32,708 | — | $0 | 32,708 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion | 2020-09-29 | 2020-09-29 | 732,137 | — | $0 | 2,268,236 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion | 2020-09-29 | 2020-09-29 | 586,099 | — | $0 | 1,536,099 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion | 2020-09-29 | 2020-09-29 | 28,129 | — | $0 | 60,837 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2020-09-29 | 2020-09-30 | 122,000 | $14.08 | $1.72M | 5,207,086 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2020-09-28 | 2020-09-30 | 93,200 | $13.03 | $1.21M | 5,085,086 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | P Buy | 2020-09-25 | 2020-09-29 | 950,000 | $18.00 | $17.10M | 950,000 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2020-09-09 | 2020-09-09 | 81,100 | $15.20 | $1.23M | 4,991,886 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2020-09-08 | 2020-09-09 | 18,800 | $14.69 | $276.2K | 4,910,786 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2020-09-04 | 2020-09-09 | 125,100 | $14.89 | $1.86M | 4,891,986 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2020-08-28 | 2020-09-01 | 1,403,509 | $14.25 | $20.00M | 4,766,886 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 9,593,086 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 158,687 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 48,691 | — | $0 | 48,691 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-29 | 1,401,448 | $19.00 | $26.63M | 4,345,016 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-29 | 23,552 | $19.00 | $447.5K | 72,243 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 2,943,568 | — | $0 | 2,943,568 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 7,064,136 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion deriv | 2020-07-21 | 2020-07-21 | 120,460 | — | $0 | 0 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion | 2020-07-21 | 2020-07-21 | 23,622 | — | $0 | 23,622 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | C Conversion | 2020-07-21 | 2020-07-21 | 1,385,291 | — | $0 | 1,385,291 | SEC↗ |
| PAND Pandion Therapeutics, Inc. | P Buy | 2020-07-21 | 2020-07-21 | 722,222 | $18.00 | $13.00M | 2,107,513 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-03-10 | 2021-03-10 | 410 | $5.60 | $2.3K | 3,578,040 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | M Exercise deriv | 2020-03-09 | 2021-03-10 | 11,971 | $5.60 | $67.0K | 3,578,450 | SEC↗ |
| INSG INSEEGO CORP. | A Award | 2019-08-09 | 2019-08-13 | 7,000 | $1000.00 | $7.00M | 7,000 | SEC↗ |
| INSG INSEEGO CORP. | M Exercise deriv | 2019-03-28 | 2019-03-29 | 3,166,275 | — | $0 | 0 | SEC↗ |
| INSG INSEEGO CORP. | A Award deriv | 2019-03-28 | 2019-03-29 | 1,875,000 | — | $0 | 1,875,000 | SEC↗ |
| INSG INSEEGO CORP. | M Exercise | 2019-03-28 | 2019-03-29 | 3,166,275 | $2.52 | $7.98M | 21,965,504 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2018-12-26 | 2018-12-27 | 25,000 | $12.47 | $311.8K | 2,978,762 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2018-12-21 | 2018-12-27 | 25,000 | $13.46 | $336.5K | 2,878,762 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2018-12-21 | 2018-12-27 | 75,000 | $13.47 | $1.01M | 2,953,762 | SEC↗ |
| INSG INSEEGO CORP. | P Buy | 2018-12-19 | 2018-12-20 | 9,752,729 | $3.00 | $29.26M | 18,799,229 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2018-11-05 | 2018-11-05 | 6,500 | $56.19 | $365.2K | 1,128,250 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2018-11-05 | 2018-11-05 | 13,610 | $59.48 | $809.5K | 1,106,250 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2018-11-05 | 2018-11-05 | 6,390 | $58.82 | $375.9K | 1,119,860 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2018-11-05 | 2018-11-05 | 2,000 | $57.38 | $114.8K | 1,126,250 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2018-11-05 | 2018-11-05 | 5,000 | $60.28 | $301.4K | 1,101,250 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2018-11-05 | 2018-11-05 | 26,500 | $55.21 | $1.46M | 1,134,750 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2018-11-02 | 2018-11-05 | 37,500 | $55.25 | $2.07M | 1,161,250 | SEC↗ |
| ESPR Esperion Therapeutics, Inc | S Sale | 2018-11-02 | 2018-11-05 | 2,500 | $54.65 | $136.6K | 1,198,750 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2018-10-24 | 2018-10-26 | 26,824 | $14.72 | $394.8K | 2,853,762 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2018-06-07 | 2018-06-11 | 193,050 | $38.85 | $7.50M | 1,565,560 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2018-03-26 | 2018-03-26 | 33,650 | $22.41 | $754.1K | 2,826,938 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2018-03-23 | 2018-03-26 | 42,943 | $23.96 | $1.03M | 2,793,288 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2018-03-22 | 2018-03-26 | 23,407 | $20.94 | $490.1K | 2,750,345 | SEC↗ |
| ODT Odonate Therapeutics, Inc. | P Buy | 2017-12-06 | 2017-12-08 | 416,666 | $24.00 | $10.00M | 2,726,938 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | X Exercise deriv | 2017-10-03 | 2017-10-03 | 189,780 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | X Exercise deriv | 2017-10-03 | 2017-10-03 | 78,186 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | X Exercise | 2017-10-03 | 2017-10-03 | 78,186 | $7.86 | $614.5K | 513,630 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | X Exercise | 2017-10-03 | 2017-10-03 | 189,780 | $7.86 | $1.49M | 1,227,774 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy deriv | 2017-01-06 | 2017-01-10 | 51,047 | $5.60 | $285.9K | 51,047 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy deriv | 2017-01-06 | 2017-01-10 | 2,341,786 | $5.60 | $13.11M | 2,341,786 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2017-01-06 | 2017-01-10 | 280,059 | $5.60 | $1.57M | 1,037,994 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2017-01-06 | 2017-01-10 | 6,104 | $5.60 | $34.2K | 435,444 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-06-13 | 2016-06-14 | 177,140 | $2.74 | $485.4K | 297,860 | SEC↗ |
| EBIO Eleven Biotherapeutics, In | S Sale | 2016-06-13 | 2016-06-14 | 864,860 | $2.74 | $2.37M | 1,390,712 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | J Other | 2016-01-04 | 2016-01-05 | 522,500 | — | $0 | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale deriv | 2015-09-17 | 2015-09-18 | 1 | $10167583.32 | $10.17M | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | S Sale deriv | 2015-09-17 | 2015-09-18 | 1 | $1522965.24 | $1.52M | 0 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2015-09-16 | 2015-09-18 | 22,500 | $45.00 | $1.01M | 522,500 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2015-09-16 | 2015-09-18 | 22,500 | $45.00 | $1.01M | 2,023,232 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2015-01-29 | 2015-02-02 | 50,000 | $20.00 | $1.00M | 2,000,732 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2015-01-29 | 2015-02-02 | 500,000 | $20.00 | $10.00M | 500,000 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | S Sale | 2014-12-15 | 2014-12-17 | 796,772 | $0.61 | $486.0K | 1,518,613 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | S Sale | 2014-12-15 | 2014-12-17 | 84,707 | $0.61 | $51.7K | 161,447 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2013-10-24 | 2013-10-28 | 40,000 | $17.50 | $700.0K | 429,341 | SEC↗ |
| MRTX Mirati Therapeutics, Inc. | P Buy | 2013-10-24 | 2013-10-28 | 360,000 | $17.50 | $6.30M | 1,950,733 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | P Buy | 2013-08-16 | 2013-08-20 | 1,450,000 | $5.00 | $7.25M | 2,315,385 | SEC↗ |
| SPHS SOPHIRIS BIO INC. | P Buy | 2013-08-16 | 2013-08-20 | 150,000 | $5.00 | $750.0K | 246,153 | SEC↗ |